Literature DB >> 17948027

Interactions of tumor cells with dendritic cells: balancing immunity and tolerance.

M V Dhodapkar1, K M Dhodapkar, A K Palucka.   

Abstract

Dendritic cells (DCs) are antigen-presenting cells specialized to initiate and maintain immunity and tolerance. DCs initiate immune responses in a manner that depends on signals they receive from pathogens, surrounding cells and their products. Most tumors are infiltrated by DCs. Thus, interactions between DCs and dying tumor cells may determine the balance between immunity and tolerance to tumor cells. In addition, DCs also display non-immunologic effects on tumors and the tumor microenvironment. Therefore, improved understanding of the cross talk between tumor cells and DCs may suggest new approaches to improve cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948027      PMCID: PMC2762352          DOI: 10.1038/sj.cdd.4402247

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  164 in total

Review 1.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

Authors:  L A Harshyne; S C Watkins; A Gambotto; S M Barratt-Boyes
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 3.  A perspective on monoclonal antibody therapy: where we have been and where we are going.

Authors:  R Levy
Journal:  Semin Hematol       Date:  2000-10       Impact factor: 3.851

Review 4.  Monoclonal antibody therapy of cancer.

Authors:  Gregory P Adams; Louis M Weiner
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

5.  Tunable antibodies.

Authors:  Louis M Weiner; Paul Carter
Journal:  Nat Biotechnol       Date:  2005-05       Impact factor: 54.908

Review 6.  Cutaneous dendritic cells.

Authors:  Jenny Valladeau; Sem Saeland
Journal:  Semin Immunol       Date:  2005-08       Impact factor: 11.130

7.  Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.

Authors:  Klaas P J M van Gisbergen; Corlien A Aarnoudse; Gerrit A Meijer; Teunis B H Geijtenbeek; Yvette van Kooyk
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 8.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

9.  A novel dendritic cell subset involved in tumor immunosurveillance.

Authors:  Julien Taieb; Nathalie Chaput; Cédric Ménard; Lionel Apetoh; Evelyn Ullrich; Mathieu Bonmort; Marie Péquignot; Noelia Casares; Magali Terme; Caroline Flament; Paule Opolon; Yann Lecluse; Didier Métivier; Elena Tomasello; Eric Vivier; François Ghiringhelli; François Martin; David Klatzmann; Thierry Poynard; Thomas Tursz; Graça Raposo; Hideo Yagita; Bernard Ryffel; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2006-01-29       Impact factor: 53.440

10.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  59 in total

Review 1.  Pharmacologically directed cell disposal: labeling damaged cells for phagocytosis as a strategy against acute pancreatitis.

Authors:  Michael Chvanov; Ole H Petersen; Alexei V Tepikin
Journal:  Mol Interv       Date:  2010-04

2.  Myeloid neighborhood in myeloma: cancer's underbelly?

Authors:  Madhav V Dhodapkar
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

Review 3.  Role of chaperones and FcgammaR in immunogenic death.

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar; Zihai Li
Journal:  Curr Opin Immunol       Date:  2008-06-21       Impact factor: 7.486

4.  Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Hiroaki Nagai; Sachin Bhusari; Hue-Hua Hong; Thai-Vu T Ton; Natasha P Clayton; Michael Wyde; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2014-06-23       Impact factor: 1.902

5.  Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.

Authors:  Alisha Holtzhausen; Fei Zhao; Kathy S Evans; Masahito Tsutsui; Ciriana Orabona; Douglas S Tyler; Brent A Hanks
Journal:  Cancer Immunol Res       Date:  2015-06-03       Impact factor: 11.151

6.  Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling.

Authors:  Iván D Mascanfroni; María del Mar Montesinos; Vanina A Alamino; Sebastián Susperreguy; Juan P Nicola; Juan M Ilarregui; Ana M Masini-Repiso; Gabriel A Rabinovich; Claudia G Pellizas
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

7.  Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway.

Authors:  Qiu-Liang Liu; Jiao Zhang; Xin Liu; Jing-Yao Gao
Journal:  Cell Prolif       Date:  2015-08-20       Impact factor: 6.831

8.  The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice.

Authors:  Fan Feng; Yao-Chun Wang; Xing-Bin Hu; Xiao-Wei Liu; Gang Ji; Yun-Ru Chen; Lin Wang; Fei He; Guo-Rui Dou; Liang Liang; Hong-Wei Zhang; Hua Han
Journal:  Mol Cancer       Date:  2010-04-27       Impact factor: 27.401

Review 9.  Ovarian cancer immunotherapy: opportunities, progresses and challenges.

Authors:  Bei Liu; John Nash; Carolyn Runowicz; Helen Swede; Richard Stevens; Zihai Li
Journal:  J Hematol Oncol       Date:  2010-02-10       Impact factor: 17.388

10.  Tumor antigen cross-presentation and the dendritic cell: where it all begins?

Authors:  Alison M McDonnell; Bruce W S Robinson; Andrew J Currie
Journal:  Clin Dev Immunol       Date:  2010-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.